Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues:    
License and other revenues
Expenses:    
Research and development 9,941 7,207
General and administrative 9,786 7,123
Total expenses 19,727 14,330
Loss from operations (19,727) (14,330)
Interest income 1,310 843
Interest expense (998) (952)
Change in fair value of warrant and derivative liabilities 7,245 (17,301)
Other income 141 162
Net loss $ (12,029) $ (31,578)
Basic loss per common share $ (0.24) $ (1.16)
Dilutive loss per common share $ (0.24) $ (1.16)
Weighted average number of common shares outstanding - basic 49,778,801 27,315,537
Weighted average number of common shares outstanding - diluted 49,778,801 27,315,537
Other comprehensive income (loss):    
Change in unrealized gains related to available-for-sale debt securities $ (75) $ (118)
Comprehensive loss $ (12,104) $ (31,696)